By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...
In new data released by the Food and Drug Administration on Wednesday, Pfizer said vaccine booster shots would restore protection against COVID-19 to up to 95% in real-world settings, CNBC and ABC ...
Pfizer and BioNTech announced Tuesday that they asked U.S. regulators to authorize a second Covid-19 vaccine booster for people 65 and older. If the Food and Drug Administration grants authorization, ...
Pfizer's CEO confirmed on Twitter that they seek emergency use authorization to provide a second COVID-19 booster shot for adults 65 years and older. Albert Bourla said that they submitted the ...
On Tuesday, the Centers for Disease Control and Prevention updated recommendations for booster shots, saying that people who got the Pfizer vaccine should now seek out a booster shot five months after ...
Pfizer on Monday announced it submitted data to the Food and Drug Administration regarding the results of Phase 1 trials for a potential COVID-19 vaccine booster shot. In a press release, Pfizer said ...